Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5795555 | 6687187 | I | 5795555-9 | 20080430 | 20080619 | 20080630 | EXP | PHHO2008US07933 | NOVARTIS PHARMACEUTICALS CORP. | F | Y | 20080627 | MD | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5795555 | 1010112658 | PS | CGS 20267 T30748+FCTAB | 2 | ORAL | 2.5 MG, QD | 20726 | ||||
| 5795555 | 1010112659 | SS | AVASTIN | 1 | INTRAVENOUS | 10 MG/KG, Q 2 WEEKS | |||||
| 5795555 | 1010112660 | SS | ADRIAMYCIN PFS | 1 | |||||||
| 5795555 | 1010112661 | C | CYTOXAN | 1 | |||||||
| 5795555 | 1010112662 | C | TAXOL | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5795555 | 1010112658 | BREAST CANCER |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5795555 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 5795555 | CARDIOTOXICITY |
| 5795555 | DYSPNOEA EXERTIONAL |
| 5795555 | EJECTION FRACTION DECREASED |
| 5795555 | FATIGUE |
| 5795555 | LEFT VENTRICULAR DYSFUNCTION |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5795555 | 1010112659 | 20070822 | 20071205 | 106 | DAY |